A number of compounds which appear to inhibit distinct biosynthetic events selectively are currently in wide use. However, variations in cellular susceptibility to these "standard" compounds often occur, thus necessitating control experiments to verify at least the gross action of any drug used in new situations. The present report concerns the synthesis of the non-virion complement-fixing antigen induced by simian virus 40 (SV40; 1) in African green monkey kidney cells (GMK) and the differential effects of two inhibitors of protein synthesis, puromycin and cycloheximide (4) , on inoculum was replaced with maintenance medium (Earle's salt solution containing Eagle's medium plus 2% calf serum).
Immunofluorescent staining was carried out by the direct method by use of a fluorescein isothiocyanate-labeled -y-globulin preparation obtained from hamsters immunized with extracts of SV40-induced transplant tumors (virus-free). Methods of washing, fixing, mounting, and examination have been described (5) . The staining characteristics of this reagent do not differ from those obtained by the indirect technique (6, 8) .
The protein inhibitors, puromycin (Nutritional Biochemicals Corp., Cleveland, Ohio) or cycloheximide (Acti-dione, The Upjohn Co., Kalamazoo, Mich.), were incorporated into the maintenance medium at various concentrations, either immediately after virus adsorption or at specified times thereafter.
Protein synthesis was estimated by the incorporation of C'4-valine into material insoluble in cold 5% trichloroacetic acid. Precipitates were collected on glass-fiber filters (type E; Gelman Instrument Co., Ann Arbor, Mich.) under vacuum, washed with 5% trichloroacetic acid, dried, and then analyzed for radioactivity by use of a liquid scintillation counter (Packard Tricarb). The kinetics of viral deoxyribonucleic acid (DNA) synthesis were inferred from infectious virus yields obtained in 72-hr cultures which had been exposed to 5-fluorodeoxyuridine (FUDR) at 50 Agg/ml for varying periods of time. The plaque assay method for SV40 has been described (2) .
The efficacy of the puromycin preparation was GILDEN AND CARP tested by its ability to inhibit the synthesis of poliovirus (type 1, Mahoney strain) in HeLa cells (10) . At specified times, cells were scraped into the medium. The cell suspension was frozen and thawed twice and then was titrated for poliovirus by a plaque assay method (3) in Rhesus monkey kidney cells.
RESULTS
In the absence of inhibitors, the maximal percentage of T antigen-positive cells (80 to 100%) was reached by 40 to 48 hr postinfection. The effects of the two protein synthesis inhibitors were evaluated on cover slips removed at 48 hr, and the results are expressed as a percentage of the untreated 48-hr value. As shown in Fig. 1 up to 22 hr postinfection was reversible with thymidine, a direct action on viral DNA synthesis is assumed. As previously reported (5, 7), T antigen synthesis proceeded at the maximal rate in the presence of FUDR.
In contrast to the cycloheximide results, puromycin at 10 Ag/ml had no effect on T antigen synthesis, even when added immediately after virus adsorption. Similar results have recently been reported (7). However, incorporation of labeled valine into protein was determined (Fig.  2) , and it was found that puromycin did not to any detectable extent suppress protein synthesis in GMK. Comparable results were obtained whether or not virus was present. In contrast, cycloheximide was rapidly effective in reducing protein synthesis by 90 to 95 %.
The efficacy of the puromycin preparation was checked by following the synthesis of poliovirus in both GMK and HeLa cells. The results (Fig. 3) show that, whereas 2 ,ug/ml of puromycin substantially inhibited poliovirus synthesis in HeLa cells, at least 100 ,ug/ml of the drug was required to achieve comparable inhibition in GMK. The latter concentration is extremely toxic for GMK.
As expected, cycloheximide at 5 lAg/ml completely prevented poliovirus replication in GMK. It thus appears quite clear that puromycin, at subtoxic doses, is ineffective as an inhibitor of protein synthesis in GMK, whereas cycloheximide is very efficient in this regard. In view of the inactivity of puromycin in GMK, the suggestion that T antigen may be a low molecular weight protein or even a small polypeptide because of insensitivity to this inhibitor (7) is unwarranted. In addition, based on gel filtration and sucrose gradient centrifugation experiments, the T antigen appears to be of relatively high molecular weight (5) . Confirmation and extension of these studies will be necessary before a definitive structure can be specified.
